1.
F Baron, S Copizza, E Baudoux, G Jerusalem, G Fillet, Y Beguin. CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer. haematol [Internet]. 2004Jan.1 [cited 2024Feb.21];89(9):1146-8. Available from: https://haematologica.org/article/view/3231